Robert Avino, MD
Adult Reconstructive Orthopaedic Surgery · Palm Beach Gardens, FLNPI 1508246083
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (41.3%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Stryker accounts for 95.9% of it on its own, with 14 other manufacturers making up the rest. 2025 is the largest year on record at $30,138, more than ten times the $2,013 reported in 2019.
Across 290 payments — averaging $161.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$45K
- Medical Device Business Services, Inc.$447
- Smith+Nephew$355
- Johnson & Johnson$263
- Medtronic$231
- Zimmer Biomet$214
- plus $400 from 9 others
What the payments were for
- Consulting fees$19,40041%
- Travel & lodging$12,06026%
- Food & beverage$15,04132%
- Education$4471%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 252 | $45,038 |
| Medical Device Business Services, Inc. | 4 | $447 |
| Smith+Nephew | 8 | $355 |
| Johnson & Johnson(2 entities) | 8 | $263 |
| Medtronic | 2 | $231 |
| Zimmer Biomet | 2 | $214 |
| Orthofix Medical, Inc. | 3 | $108 |
| Abbott | 1 | $89 |
| Heron Therapeutics, Inc. | 2 | $47 |
| Bioventus LLC | 2 | $45 |
| KCI USA, Inc. | 2 | $43 |
| Microport Orthopedics Inc | 1 | $23 |
| Fidia Pharma USA Inc. | 1 | $19 |
| Convatec Inc. | 1 | $18 |
| Dynasplint Systems Inc. | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$36,654
- INSIGNIA$1,836
- ACCOLADE$1,025
- TRIDENT$768
- TRITANIUM$622
- RESTORATION$622
- ClosureFast$193
- EXETER$146
- TRIATHLON$146
- TRAUMA$145
- INTERMAXILLARY FIXATION$141
- Journey II$139
- Arcos$119
- Oss-Hips$119
- Rosa-Hip$119
How this compares
$46,948 in reported general payments places this provider in the 70th percentile of 96 adult reconstructive orthopaedic surgery providers in Florida.
See all adult reconstructive orthopaedic surgery providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 207 | $5,880 |
| EliquisApixaban | 13 | $5,723 |
| Meloxicam | 336 | $1,116 |
| Ondansetron Hcl | 185 | $754 |
| Tramadol Hcl | 187 | $647 |
| Oxycodone Hcl | 65 | $360 |
| Diclofenac Sodium | 37 | $263 |
| Omeprazole | 25 | $193 |
| Amoxicillin | 70 | $187 |
| Methylprednisolone | 13 | $94 |
| Clindamycin Hcl | 22 | $84 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Palm Beach Gardens
- Andrew NoblePalm Beach Gardens$308K
- Jonathan ShawPalm Beach Gardens$20K
- Carlos LaverniaMiami$5.4M
- Juan SuarezMiami$3.9M
- John RedmondJacksonville$987K
- Gavan DuffyJacksonville$543K
- Timothy van de LeurSummerfield$511K
- Edward StolarskiSarasota$445K
- Raul GostheMiami$252K
- Chancellor GrayGainesville$228K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.